In a recent study at the University of California San Diego, researchers found that a new tumor-penetrating therapy may enhance the effects of chemotherapy, reduce metastasis and increase survival in pancreatic cancer.
They showed how a tumor-targeting peptide, called iRGD, can sneak inside the armor that the tumor built to protect itself and destroy the tumor from within.
The study is published in Nature Communications. One author is Tatiana Hurtado de Mendoza, Ph.D.
Every 12 minutes, someone in the United States dies of pancreatic cancer, which is often diagnosed late, spreads rapidly, and has a five-year survival rate of approximately 10%.
The pancreas is a large gland located behind the stomach. It makes enzymes that aid digestion and hormones that regulate blood sugar levels.
Pancreatic ductal adenocarcinoma (PDAC) is a subtype of pancreatic cancer that is highly drug-resistant due, in part, to the hard shell-like outer layer surrounding the tumor.
Treatment may involve radiation, surgery and chemotherapy, though often cancer becomes resistant to drugs.
In the study, the team examined the microenvironment of PDAC tumors in a mouse model.
They found that after targeting the tumor blood vessels, iRGD binds to high levels of a protein that produces much of the tumor’s protective fibrous cover.
They showed that when iRGD was injected with chemotherapy with high levels of β5 integrin, there was a big increase in survival and a reduction in cancer spreading to other organs in the body compared to chemotherapy alone.
This could be a powerful treatment strategy to target aggressive pancreatic cancer.
In addition, the new therapy did not produce any additional side effects. This is critically important when considering treatments for patients.
The researchers said the next steps include a national human clinical trial. They estimate the trial could begin in one year.
If you care about pancreatic cancer, please read studies about this common health condition may increase pancreatic cancer risk and findings of one big cause of pancreatic cancer.
For more information about pancreatic cancer treatment and prevention, please see recent studies about the key to stopping the spread of pancreatic cancer and results showing that a new drug could improve survival in pancreatic cancer.
Copyright © 2021 Knowridge Science Report. All rights reserved.
